Technical Analysis for PRTK - Paratek Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 5.42 -1.81% -0.10
PRTK closed down 1.81 percent on Thursday, July 29, 2021, on 11 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Aug 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical PRTK trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -1.81%
Oversold Stochastic Weakness -1.81%
Wide Bands Range Expansion 1.88%
Older End-of-Day Signals for PRTK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 4 hours ago
Possible Inside Day about 5 hours ago
Possible NR7 about 5 hours ago
Down 1% about 6 hours ago
60 Minute Opening Range Breakdown about 8 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Paratek Pharmaceuticals, Inc. Description

Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Organ Systems Antibiotic Infection Multiple Sclerosis SMS Bacterial Infections Antibiotics Acne Hepatotoxins Pneumonia Urinary Tract Infection Rosacea Urinary Tract Infections Skin And Skin Structure Infection Skin And Skin Structure Infections Bacterial Pneumonia Community Acquired Bacterial Pneumonia Omadacycline Tetracycline

Is PRTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.235
52 Week Low 4.11
Average Volume 609,636
200-Day Moving Average 7.01
50-Day Moving Average 7.60
20-Day Moving Average 6.12
10-Day Moving Average 5.62
Average True Range 0.36
ADX 41.54
+DI 9.84
-DI 28.47
Chandelier Exit (Long, 3 ATRs) 6.20
Chandelier Exit (Short, 3 ATRs) 6.32
Upper Bollinger Bands 7.26
Lower Bollinger Band 4.99
Percent B (%b) 0.19
BandWidth 37.05
MACD Line -0.60
MACD Signal Line -0.60
MACD Histogram 0.0046
Fundamentals Value
Market Cap 247.38 Million
Num Shares 45.6 Million
EPS -3.85
Price-to-Earnings (P/E) Ratio -1.41
Price-to-Sales 6.68
Price-to-Book 0.00
PEG Ratio -0.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.68
Resistance 3 (R3) 5.70 5.64 5.63
Resistance 2 (R2) 5.64 5.58 5.63 5.62
Resistance 1 (R1) 5.53 5.53 5.50 5.51 5.60
Pivot Point 5.47 5.47 5.46 5.46 5.47
Support 1 (S1) 5.36 5.41 5.33 5.34 5.24
Support 2 (S2) 5.30 5.36 5.29 5.22
Support 3 (S3) 5.19 5.30 5.21
Support 4 (S4) 5.17